Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-10
2006-10-10
Saeed, Kamal A. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S468000, C544S375000, C544S153000, C546S187000, C548S525000, C548S543000, C548S568000
Reexamination Certificate
active
07119214
ABSTRACT:
The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions of compounds of Formula (A):wherein Ar, Y, R1and q are as defined herein; and their use in the treatment of diseases, including treatment of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder (“ADHD”), enhancing function in disorders associated with hypofunctionality of the cerebral cortex, including, but not limited to, depression, schizophrenia, fatigue, in particular, fatigue associated with neurologic disease, such as multiple sclerosis, chronic fatigue syndrome, and improvement of cognitive dysfunction.
REFERENCES:
patent: 4066686 (1978-01-01), Lafon
patent: 4177290 (1979-12-01), Lafon
patent: 4927855 (1990-05-01), Lafon
patent: 4935240 (1990-06-01), Nakai et al.
patent: 4980372 (1990-12-01), Nakai et al.
patent: 5180745 (1993-01-01), Lafon
patent: 5391576 (1995-02-01), Lafon, deceased
patent: 5401776 (1995-03-01), Laurent
patent: 5563169 (1996-10-01), Yoshida et al.
patent: 5612379 (1997-03-01), Laurent
patent: 5719168 (1998-02-01), Laurent
patent: 6346548 (2002-02-01), Miller et al.
patent: 6455588 (2002-09-01), Scammell et al.
patent: 6488164 (2002-12-01), Miller et al.
patent: 6492396 (2002-12-01), Bacon et al.
patent: 0 105 397 (1984-04-01), None
patent: 0 121 716 (1984-10-01), None
patent: 0 387 603 (1990-09-01), None
patent: 1 136 477 (2001-09-01), None
patent: 0 4290 980.4 (2004-04-01), None
patent: 1 411 052 (2004-04-01), None
patent: WO 95/01171 (1995-01-01), None
patent: WO 93/05033 (1995-03-01), None
patent: WO 99/25329 (1999-05-01), None
patent: WO 01/87830 (2001-11-01), None
patent: WO 02/10125 (2002-02-01), None
patent: WO 03/002531 (2003-01-01), None
patent: WO 03/029212 (2003-04-01), None
patent: WO 03/037853 (2003-05-01), None
patent: WO2004/037805 (2004-05-01), None
Annis, I., et al., “Novel solid-phase reagents for facile formation of intramolecular disulfide bonds in peptides under mild conditions,”Pept. Proc. Am. Pept. Symp. 15th, meeting dated 1997, 1999, 343-344.
Cagniant, P., et al., “Syntheses beginning with 2-chloromethylbenzo 'b! furan. 3,4-dihydro-1H-thieno ‘3,4-b!benzo’1!furan, 1H-thieno 3,4- b!benzo furan, and their derivatives and 6,12-dihydro-12-oxobenzothiepino ‘3,4-benzo’1!furan,”Chem. Abstracts Ser., Accession No. 72825, 1975, 2 pages.
Cagniant, P., “4,5!thieno 3,2-c!thiopyrans,”Chem. Abstracts Ser., Accession No. 420242, 1971, 1 page.
Dzvinchuk, B., “Recyclization in hydration of 3-formyl-2-phenyl-1,4-benzodioxin,”Chem. Of Heterocy. Compds, 1999, 35(10), 1480-1481.
Edgar, D.M., “CCD-3693: an orally bioavailable analog of the endo genous neuroactive steroid, pregnanolone, demonstrates potent sedative hypnotic actions in the rat,”J. of Pharmacol.&Exp. Ther., 1997, 282(1), 420-429.
Edgar, D.M., et al., “Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat,”J. of Pharm.&Experi. Therap., 1997, 283, 757-769.
El-Sakka, I.A., et al., “Reactions with thiaxanthen-9-o1: new thiaxanthene derivatives with molluscicidal and nematocidal activity,”Arch. Pharm.(Weinheim), 1994, 327, 133-135.
Farina, G., “1,4-Benzodioxins from 1,4-Benzodioxans,”Synthesis, 1977, p. 755.
Han, Y., et al., “Novel S-Xanthenyl protecting groups for cysteine and their applications for the Na-9-fluorenylmethyloxcarbonyl (Fmoc) strategy of peptide synthesis,”Org. Chem., 1997, 62, 3841-3848.
Hermant, J.-F., et al., “Awakening properties of modafinil: effect on nocturnal activity in monkeys (Macaca mulatta) after acute and repeated adminstration,”Psychopharmacology, 1991, 103, 28-32.
Imeri, L., et al., “Blockade of 5-hydroxytryptamine (serotonin)-receptors alters interleukin-1-induced changes in rat sleep,”Neurosci., 1999, 92(2), 745-749.
Lee, T.V., “Synthetic studies on 1,4-benzodioxin: the preparation of analogues of biologically important indoles,”Tetrahedron, 1990, 46(3), 921-934 (abstract 1 page).
Lehninger, A.L., “The amino acid building blocks of proteins,”Biochemistry. 2ndEd., Worth Publishers, NY, 1975, 71-77.
Lin, J.S., et al., “Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat,”Brain Res., 1992, 591, 319-326.
Opp, M.R., et al., “Anti-interleukin-1β reduces sleep and sleep rebound after sleep deprivation in rats,”Am. J. of Physiol., 1994, R688-R695.
Opp, M.R., et al., “Rat strain differences suggest a role for corticotrophin-releasing hormone in modulating sleep,”Physiol.&Behav., 1998, 63(I), 67-74.
Panckeri, K.A., et al., “Modafinil decreases hypersomnolence in the English bulldog, a natural animal model of sleep-disordered breathing,”Sleep, 1996, 19(8), 626-631.
Piotrowska, H., et al., “New sulfur derivatives of indole,”Chem. Abstracts Ser., Accession No. 494178, 1978, 2 pages.
Seidel, W.F., et al., “Alpha-2 adrenergic modulation of sleep: time-of-day dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat,”J. of Pharmacol. Exp. Ther., 1995, 275(1), 263-273.
Shelton, J., et al., “Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs,”Sleep, 1995, 18(10), 817-826.
Terauchi, H., et al., “Nicotinamide derivatives as a new class of gastric H+/K+-ATPase inhibitors. 1. Synthesis and structure-activity relationships of N-substituted 2-(benzhydryl- and benzylsulfinyl)nicotinamides,”J. of Med. Chem., 1997, 40, 313-321.
Touret, M., et al., “Awakening properties of modafinil without paradoxical sleep rebound: comparative study with amphetamine in the rat,”Neurosc. Letts., 1995, 189, 43-46.
Van Gelder, R.N., et al., “Real-time automated sleep scoring: validation of a microcomputer-based system for mice,”Sleep, 1991, 14(1), 48-55.
Welsh, D.K., et al., “A circadian rhythm of hippocampal theta activity in the mouse,”Physiol.&Behav., 1985, 35, 533-538.
Chasset Sophie
Lesur Brigitte
Renault Olivier
Yue Christophe
Cephalon France
Chu Yong
Woodcock & Washburn LLP
LandOfFree
Thio-substituted tricyclic and bicyclic aromatic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thio-substituted tricyclic and bicyclic aromatic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thio-substituted tricyclic and bicyclic aromatic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3707877